1.
Ding T, Hardiman PJ, Petersen I, Wang FF, Qu F, Baio G. The prevalence of polycystic
ovary syndrome in reproductive-aged women of different ethnicity: a systematic review
and meta-analysis. Oncotarget. 2017;8(56):96351-8.
2.
Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and
treatment. Nature reviews Endocrinology. 2018;14(5):270-84.
3.
Hemati T, Moghadami-Tabrizi N, Davari-Tanha F, Salmanian B, Javadian P. High plasma
homocysteine and insulin resistance in patients with polycystic ovarian syndrome.
Iranian journal of reproductive medicine. 2011;9(3):223-8.
4.
Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological,
reproductive and metabolic manifestations that impacts on health across the lifespan.
BMC medicine. 2010;8:41.
5.
Diamond MP, Legro RS, Coutifaris C, Alvero R, Robinson RD, Casson PA, et al. Sexual
function in infertile women with polycystic ovary syndrome and unexplained infertility.
Am J Obstet Gynecol. 2017;217(2):191 e1- e19.
6.
Noroozzadeh M, Tehrani FR, Mobarakabadi SS, Farahmand M, Dovom MR. Sexual function
and hormonal profiles in women with and without polycystic ovary syndrome: a population-based
study. International journal of impotence research. 2017;29(1):1-6.
7.
Geiss IM, Umek WH, Dungl A, Sam C, Riss P, Hanzal E. Prevalence of female sexual dysfunction
in gynecologic and urogynecologic patients according to the international consensus
classification. Urology. 2003;62(3):514-8.
8.
Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, et al. Report
of the international consensus development conference on female sexual dysfunction:
definitions and classifications. The Journal of urology. 2000;163(3):888-93.
9.
Aslan E, Fynes M. Female sexual dysfunction. International urogynecology journal and
pelvic floor dysfunction. 2008;19(2):293-305.
10.
Berman JR, Goldstein I. Female sexual dysfunction. The Urologic clinics of North America.
2001;28(2):405-16.
11.
Worsley R, Santoro N, Miller KK, Parish SJ, Davis SR. Hormones and Female Sexual Dysfunction:
Beyond Estrogens and Androgens--Findings from the Fourth International Consultation
on Sexual Medicine. J Sex Med. 2016;13(3):283-90.
12.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual
Function Index (FSFI): a multidimensional self-report instrument for the assessment
of female sexual function. Journal of sex & marital therapy. 2000;26(2):191-208.
13.
Elsenbruch S, Hahn S, Kowalsky D, Offner AH, Schedlowski M, Mann K, et al. Quality
of life, psychosocial well-being, and sexual satisfaction in women with polycystic
ovary syndrome. The Journal of clinical endocrinology and metabolism. 2003;88(12):5801-7.
14.
Drosdzol A, Skrzypulec V, Mazur B, Pawlinska-Chmara R. Quality of life and marital
sexual satisfaction in women with polycystic ovary syndrome. Folia histochemica et
cytobiologica. 2007;45 Suppl 1:S93-7.
15.
Battaglia C, Nappi RE, Mancini F, Cianciosi A, Persico N, Busacchi P, et al. PCOS,
sexuality, and clitoral vascularisation: a pilot study. The journal of sexual medicine.
2008;5(12):2886-94.
16.
Mansson M, Norstrom K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landen M. Sexuality
and psychological wellbeing in women with polycystic ovary syndrome compared with
healthy controls. European journal of obstetrics, gynecology, and reproductive biology.
2011;155(2):161-5.
17.
Stovall DW, Scriver JL, Clayton AH, Williams CD, Pastore LM. Sexual function in women
with polycystic ovary syndrome. The journal of sexual medicine. 2012;9(1):224-30.
18.
Ercan CM, Coksuer H, Aydogan U, Alanbay I, Keskin U, Karasahin KE, et al. Sexual dysfunction
assessment and hormonal correlations in patients with polycystic ovary syndrome. International
journal of impotence research. 2013;25(4):127-32.
19.
Ferraresi SR, Lara LA, Reis RM, Rosa e Silva AC. Changes in sexual function among
women with polycystic ovary syndrome: a pilot study. The journal of sexual medicine.
2013;10(2):467-73.
20.
Morotti E, Persico N, Battaglia B, Fabbri R, Meriggiola MC, Venturoli S, et al. Body
imaging and sexual behavior in lean women with polycystic ovary syndrome. The journal
of sexual medicine. 2013;10(11):2752-60.
21.
De Frene V, Verhofstadt L, Loeys T, Stuyver I, Buysse A, De Sutter P. Sexual and relational
satisfaction in couples where the woman has polycystic ovary syndrome: a dyadic analysis.
Human reproduction. 2015;30(3):625-31.
22.
Benetti-Pinto CL, Ferreira SR, Antunes A, Jr., Yela DA. The influence of body weight
on sexual function and quality of life in women with polycystic ovary syndrome. Archives
of gynecology and obstetrics. 2015;291(2):451-5.
23.
Kowalczyk R, Skrzypulec-Plinta V, Nowosielski K, Lew-Starowicz Z. Sexuality in women
with polycystic ovary syndrome. Ginekologia polska. 2015;86(2):100-6.
24.
Lara LA, Ramos FK, Kogure GS, Costa RS, Silva de Sa MF, Ferriani RA, et al. Impact
of Physical Resistance Training on the Sexual Function of Women with Polycystic Ovary
Syndrome. The journal of sexual medicine. 2015;12(7):1584-90.
25.
Veras AB, Bruno RV, de Avila MA, Nardi AE. Sexual dysfunction in patients with polycystic
ovary syndrome: clinical and hormonal correlations. Comprehensive psychiatry. 2011;52(5):486-9.
26.
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S.
Sexual Functioning among Married Iranian Women with Polycystic Ovary Syndrome. International
journal of fertility & sterility. 2014;8(3):273-80.
27.
Eftekhar T, Sohrabvand F, Zabandan N, Shariat M, Haghollahi F, Ghahghaei-Nezamabadi
A. Sexual dysfunction in patients with polycystic ovary syndrome and its affected
domains. Iranian journal of reproductive medicine. 2014;12(8):539-46.
28.
Hashemi S, Ramezani Tehrani F, Farahmand M, Bahri Khomami M. Association of PCOS and
its clinical signs with sexual function among Iranian women affected by PCOS. The
journal of sexual medicine. 2014;11(10):2508-14.
29.
Dashti S, Latiff LA, Hamid HA, Sani SM, Akhtari-Zavare M, Abu Bakar AS, et al. Sexual
Dysfunction in Patients with Polycystic Ovary Syndrome in Malaysia. Asian Pacific
journal of cancer prevention : APJCP. 2016;17(8):3747-51.
30.
Noroozzadeh M, Ramezani Tehrani F, Bahri Khomami M, Azizi F. A Comparison of Sexual
Function in Women with Polycystic Ovary Syndrome (PCOS) Whose Mothers Had PCOS During
Their Pregnancy Period with Those Without PCOS. Archives of sexual behavior. 2017;46(7):2033-42.
31.
Nasiri Amiri F, Ramezani Tehrani F, Esmailzadeh S, Tohidi M, Azizi F, Basirat Z. Sexual
function in women with polycystic ovary syndrome and their hormonal and clinical correlations.
International journal of impotence research. 2018;30(2):54-61.
32.
Pastoor H, Timman R, de Klerk C, Bramer WM, Laan ETM, Laven JSE. Sexual function in
women with Polycystic Ovary Syndrome: a systematic review and meta-analysis. Reproductive
biomedicine online. 2018.
33.
Wierman ME, Nappi RE, Avis N, Davis SR, Labrie F, Rosner W, et al. Endocrine aspects
of women's sexual function. J Sex Med. 2010;7(1 Pt 2):561-85.
34.
Ching HL, Burke V, Stuckey BGA. Quality of life and psychological morbidity in women
with polycystic ovary syndrome: body mass index, age and the provision of patient
information are significant modifiers. Clinical endocrinology. 2007;66(3):373-9.
35.
Månsson M, Norström K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landén M. Sexuality
and psychological wellbeing in women with polycystic ovary syndrome compared with
healthy controls. European journal of obstetrics & gynecology and reproductive biology.
2011;155(2):161-5.
36.
Elsenbruch S, Hahn S, Kowalsky D, Öffner AH, Schedlowski M, Mann K, et al. Quality
of life, psychosocial well-being, and sexual satisfaction in women with polycystic
ovary syndrome. The journal of clinical endocrinology & metabolism. 2003;88(12):5801-7.
37.
Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus
on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored
3rd PCOS consensus workshop group. Fertility and sterility. 2012;97(1):28-38. e25.
38.
Janssen OE, Hahn S, Tan S, Benson S, Elsenbruch S. Mood and sexual function in polycystic
ovary syndrome. Semin Reprod Med. 2008;26(1):45-52.
39.
Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D. Sexual dysfunction
in women with the metabolic syndrome. Diabetes care. 2005;28(3):756.
40.
Murri M, Insenser M, Fernández-Durán E, San-Millán JL, Escobar-Morreale HF. Effects
of polycystic ovary syndrome (PCOS), sex hormones, and obesity on circulating miRNA-21,
miRNA-27b, miRNA-103, and miRNA-155 expression. The journal of clinical endocrinology
& metabolism. 2013;98(11):E1835-E44.
41.
Blank SK, McCartney CR, Chhabra S, Helm KD, Eagleson CA, Chang RJ, et al. Modulation
of gonadotropin-releasing hormone pulse generator sensitivity to progesterone inhibition
in hyperandrogenic adolescent girls--implications for regulation of pubertal maturation.
J Clin Endocrinol Metab. 2009;94(7):2360-6.
42.
Shifren JL, editor The role of androgens in female sexual dysfunction. Mayo Clinic
Proceedings; 2004: Mayo Foundation for Medical Education and Research.
43.
Khera M. Testosterone therapy for female sexual dysfunction. Sexual medicine reviews.
2015;3(3):137-44.
44.
Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with
endocrine disorders. The Lancet. 2007;369(9561):597-611.
45.
Veras AB, Bruno RV, de Avila MAP, Nardi AE. Sexual dysfunction in patients with polycystic
ovary syndrome: clinical and hormonal correlations. Comprehensive psychiatry. 2011;52(5):486-9.
46.
Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycystic ovary syndrome:
evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator
to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 1998;83(2):582-90.
47.
Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, et al. Determinants
of abnormal gonadotropin secretion in clinically defined women with polycystic ovary
syndrome. J Clin Endocrinol Metab. 1997;82(7):2248-56.
48.
Hahn S, Benson S, Elsenbruch S, Pleger K, Tan S, Mann K, et al. Metformin treatment
of polycystic ovary syndrome improves health-related quality-of-life, emotional distress
and sexuality. Hum Reprod. 2006;21(7):1925-34.
49.
Conaglen HM, Conaglen JV. Sexual desire in women presenting for antiandrogen therapy.
J Sex Marital Ther. 2003;29(4):255-67.